Development
The Clorox Company
CLX
$122.17
$0.590.49%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 7.31B | 7.04B | 7.39B | 7.17B | 7.07B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.31B | 7.04B | 7.39B | 7.17B | 7.07B |
| Cost of Revenue | 4.24B | 4.21B | 4.48B | 4.46B | 4.50B |
| Gross Profit | 3.07B | 2.82B | 2.91B | 2.71B | 2.56B |
| SG&A Expenses | 2.00B | 1.93B | 1.92B | 1.84B | 1.71B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 34.00M | 32.00M | 36.00M | 21.00M | 24.00M |
| Total Operating Expenses | 6.41B | 6.31B | 6.58B | 6.45B | 6.37B |
| Operating Income | 899.00M | 726.00M | 809.00M | 721.00M | 697.00M |
| Income Before Tax | 157.00M | 151.00M | 238.00M | 130.00M | 575.00M |
| Income Tax Expenses | 64.00M | 52.00M | 77.00M | 46.00M | 130.00M |
| Earnings from Continuing Operations | 93.00 | 99.00 | 161.00 | 84.00 | 445.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -13.00M | -13.00M | -12.00M | -10.00M | -10.00M |
| Net Income | 80.00M | 86.00M | 149.00M | 74.00M | 435.00M |
| EBIT | 899.00M | 726.00M | 809.00M | 721.00M | 697.00M |
| EBITDA | 1.13B | 957.00M | 1.04B | 944.00M | 917.00M |
| EPS Basic | 0.64 | 0.69 | 1.21 | 0.60 | 3.53 |
| Normalized Basic EPS | 3.97 | 3.16 | 3.59 | 3.09 | 2.99 |
| EPS Diluted | 0.62 | 0.67 | 1.18 | 0.59 | 3.51 |
| Normalized Diluted EPS | 3.95 | 3.15 | 3.58 | 3.08 | 2.97 |
| Average Basic Shares Outstanding | 495.62M | 494.99M | 494.36M | 493.76M | 493.29M |
| Average Diluted Shares Outstanding | 497.56M | 496.93M | 496.19M | 495.35M | 495.57M |
| Dividend Per Share | 4.78 | 4.76 | 4.74 | 4.72 | 4.70 |
| Payout Ratio | 737.50% | 682.56% | 391.28% | 783.78% | 132.64% |